A detailed history of Cubic Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cubic Asset Management, LLC holds 45,710 shares of BMY stock, worth $2.65 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
45,710
Previous 44,655 2.36%
Holding current value
$2.65 Million
Previous $2.29 Million 8.16%
% of portfolio
0.59%
Previous 0.6%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$47.98 - $54.4 $50,618 - $57,392
1,055 Added 2.36%
45,710 $2.48 Million
Q4 2023

Jan 24, 2024

SELL
$48.48 - $57.85 $46,056 - $54,957
-950 Reduced 2.08%
44,655 $2.29 Million
Q3 2023

Nov 01, 2023

SELL
$57.89 - $64.73 $249,911 - $279,439
-4,317 Reduced 8.65%
45,605 $2.65 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $18,475 - $20,514
290 Added 0.58%
49,922 $3.19 Million
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $28,255 - $32,047
-430 Reduced 0.86%
49,632 $3.44 Million
Q4 2022

Jan 30, 2023

SELL
$68.48 - $81.09 $195,168 - $231,106
-2,850 Reduced 5.39%
50,062 $3.6 Million
Q3 2022

Oct 24, 2022

SELL
$0.13 - $76.84 $19 - $11,526
-150 Reduced 0.28%
52,912 $3.76 Million
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $65,721 - $72,381
-905 Reduced 1.68%
53,062 $4.09 Million
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $42,904 - $50,016
-800 Reduced 1.46%
53,967 $3.37 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $983,287 - $1.15 Million
16,618 Added 43.56%
54,767 $3.24 Million
Q3 2021

Oct 25, 2021

SELL
$59.17 - $69.31 $997,487 - $1.17 Million
-16,858 Reduced 30.65%
38,149 $2.23 Million
Q2 2021

Jul 23, 2021

BUY
$61.91 - $67.42 $63,457 - $69,105
1,025 Added 1.9%
55,007 $3.68 Million
Q1 2021

Apr 26, 2021

SELL
$59.34 - $66.74 $1,780 - $2,002
-30 Reduced 0.06%
53,982 $3.41 Million
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $86,610 - $98,145
1,500 Added 2.86%
54,012 $3.35 Million
Q3 2020

Oct 27, 2020

BUY
$57.43 - $63.64 $172,290 - $190,920
3,000 Added 6.06%
52,512 $3.17 Million
Q2 2020

Jul 24, 2020

BUY
$54.82 - $64.09 $68,250 - $79,792
1,245 Added 2.58%
49,512 $2.91 Million
Q1 2020

Apr 27, 2020

BUY
$46.4 - $67.43 $158,780 - $230,745
3,422 Added 7.63%
48,267 $2.69 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $129,668 - $169,140
2,635 Added 6.24%
44,845 $2.88 Million
Q3 2019

Oct 28, 2019

BUY
$42.77 - $50.71 $225,825 - $267,748
5,280 Added 14.3%
42,210 $2.14 Million
Q2 2019

Jul 29, 2019

BUY
$44.62 - $49.34 $88,436 - $97,791
1,982 Added 5.67%
36,930 $1.68 Million
Q1 2019

Apr 29, 2019

SELL
$45.12 - $53.8 $7,986 - $9,522
-177 Reduced 0.5%
34,948 $1.67 Million
Q4 2018

Jan 28, 2019

SELL
$48.76 - $63.23 $2,438 - $3,161
-50 Reduced 0.14%
35,125 $1.83 Million
Q3 2018

Oct 25, 2018

SELL
$55.19 - $62.25 $38,633 - $43,575
-700 Reduced 1.95%
35,175 $2.18 Million
Q2 2018

Jul 25, 2018

SELL
$50.53 - $62.98 $108,588 - $135,344
-2,149 Reduced 5.65%
35,875 $1.99 Million
Q1 2018

Apr 24, 2018

BUY
$59.92 - $68.98 $1,498 - $1,724
25 Added 0.07%
38,024 $2.41 Million
Q4 2017

Jan 24, 2018

SELL
$59.94 - $65.35 $44,955 - $49,012
-750 Reduced 1.94%
37,999 $2.33 Million
Q3 2017

Oct 26, 2017

BUY
$55.23 - $63.74 $2.14 Million - $2.47 Million
38,749
38,749 $2.47 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cubic Asset Management, LLC Portfolio

Follow Cubic Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubic Asset Management, LLC with notifications on news.